Clinical Trials Browser

eribulin × Gynecologic × 1 year × Clear all

NCT01676818 2025-11-06

Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer

Phase 2 Completed

32 enrolled 17 charts

Uterine Cervical Neoplasms